Erdafitinib
CAS 1346242-81-6
FGFR inhibitor
Oncology & Targeted Therapies
Targeted oncology agents and precision therapeutics for clinical and translational research.
Pemigatinib
CAS 1503315-51-2
FGFR2 inhibitor
Futibatinib
CAS 1448428-04-3
FGFR inhibitor, irreversible
Infigratinib
CAS 872511-34-7
FGFR inhibitor
Rogaratinib
CAS 1443702-98-6
FGFR inhibitor
ASP5878
CAS 1453208-66-6
FGFR inhibitor
Dabogratinib (TYRA-300)
CAS 2800223-30-5
FGFR3 inhibitor
Vepugratinib (LOXO-435)
CAS 2833703-74-3
FGFR3 inhibitor
Lorlatinib
CAS 1454846-35-5
ALK inhibitor
Osimertinib
CAS 1421373-65-0
EGFR inhibitor
Gefitinib
CAS 184475-35-2
EGFR inhibitor
Erlotinib Hydrochloride
CAS 183319-69-9
EGFR inhibitor
Afatinib
CAS 850140-72-6
ErbB family inhibitor
Alectinib
CAS 1256580-46-7
ALK inhibitor
Crizotinib
CAS 877399-52-5
ALK/ROS1 inhibitor
Brigatinib
CAS 1197953-54-0
ALK inhibitor
Ibrutinib
CAS 936563-96-1
BTK inhibitor
Acalabrutinib
CAS 1420477-60-6
BTK inhibitor
Zanubrutinib
CAS 1691249-45-2
BTK inhibitor
Olaparib
CAS 763113-22-0
PARP inhibitor
Niraparib
CAS 1038915-60-4
PARP inhibitor
Rucaparib
CAS 283173-50-2
PARP inhibitor
Ribociclib
CAS 1211441-98-3
CDK4/6 inhibitor
Palbociclib
CAS 571190-30-2
CDK4/6 inhibitor
Abemaciclib
CAS 1231929-97-7
CDK4/6 inhibitor
Trametinib
CAS 871700-17-3
MEK inhibitor
Cobimetinib
CAS 934660-93-2
MEK inhibitor
Selumetinib
CAS 606143-89-9
MEK inhibitor
Alpelisib
CAS 1217486-61-7
PI3K inhibitor
Copanlisib
CAS 1032568-63-0
PI3K inhibitor
Idelalisib
CAS 870281-82-6
PI3K inhibitor
Ruxolitinib
CAS 941678-49-5
JAK1/2 inhibitor
Tofacitinib
CAS 477600-75-2
JAK inhibitor
Fedratinib
CAS 936091-14-4
JAK2 inhibitor
Sotorasib
CAS 2252403-56-6
KRAS G12C inhibitor
Adagrasib
CAS 2296729-00-3
KRAS G12C inhibitor
Venetoclax
CAS 1257044-40-8
BCL-2 inhibitor
Need a custom chemical or bulk supply?
We handle custom inquiries and special sourcing requests.
Request a quote